Navigation Links
PreMD Appeals American Stock Exchange Delisting Notification
Date:6/4/2008

TORONTO, June 4 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today announced that it will appeal the recent decision made by American Stock Exchange (the "AMEX") to delist its stock on the Exchange. During the appeal determination process, the Company's stock will continue to trade on the AMEX under the symbol PME. PreMD also continues to trade on the Toronto Stock Exchange (the "TSX") under the symbol PMD.

"We believe that our plans will allow PreMD to meet every objective standard for continued listing of its common stock on the American Stock Market and we look forward to the opportunity to present our appeal of the proposed delisting," said Brent Norton, president and CEO of PreMD.

In accordance with applicable AMEX rules, the Company has appealed the proposed delisting and requested a hearing before an AMEX Listing Qualifications Panel. There can be no assurance that the Company's appeal will be successful or that the Company's request for continued listing (or any delay in delisting) by AMEX will be granted.

About PreMD Inc.

PreMD Inc. is a leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. PreMD's cardiovascular products include a line of non-invasive skin cholesterol tests. PreMD's other skin cholesterol products include PREVU(x) LT, a skin cholesterol test designed for use in the life insurance industry. The Company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. PreMD's head office is located in Toronto, Ontario and its research and product development facility is at McMaster University in Hamilton, Ontario. For more information about PreMD, please visit http://www.premdinc.com.

This press release contains forward-looking statements. These statements involve known and unknown risks and uncertainties, which c
'/>"/>

SOURCE PreMD Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PreMD Reports First Quarter Results
2. PreMD Provides Update on FDA Review
3. PreMD Reports Fiscal 2007 Results
4. PreMD Inc. Completes Debenture Financing
5. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
6. PreMD Inc. Announces Debenture Financing
7. PreMD Initiates FDA Review Process and Provides Corporate Update
8. PreMD Announces FDA Decision on POC Skin Cholesterol Test
9. PreMD Announces Valuable Data on PREVU(x) LT Life Insurance Product
10. PreMD Inc. Provides Corporate Update
11. PreMD Provides Update on 510(k) Application for PREVU(x) POC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... anxiety, excessive perspiration these symptoms are a few ... the body,s heart rate and plays a crucial role ... from Tel Aviv University points to an additional complication ... published in Mammalian Genome , was conducted by ... the Department of Human Molecular Genetics and Biochemistry at ...
(Date:9/22/2014)... (Washington) The efforts and leadership of Senators ... ensure access to vital primary care services were ... (ACP) and 20 other organizations, representing internal medicine ... the senators applauds them for introducing the Ensuring ... Act, S. 2694, which will extend current-law payment ...
(Date:9/22/2014)... Riverside is one of 11 collaborating institutions that have ... National Science Foundation for a project ... that include plant symbionts, animal and human pathogens and ... Zygomycetes, used in numerous industrial processes and fermentation of ... fungi. Symbiotic associations with zygomycetes may have facilitated the ...
(Date:9/22/2014)... Don Allred Insurance is pleased to announce ... NC. The satellite office, located in the Holly Hill Mall ... 2014, and offer all of the same professional services as ... Insurance spokesperson Scott Allred cites an expanding client base and ... of the major factors driving the decision to open a ...
(Date:9/22/2014)... California (PRWEB) September 22, 2014 ... care market occupies a significant presence in the ... most widespread healthcare problems globally. Key factors underlying ... lifestyle habits such as smoking; increasing levels of ... and expanding base of aging population vulnerable to ...
Breaking Medicine News(10 mins):Health News:Lack of thyroid hormone blocks hearing development 2Health News:Broad physician coalition urges Congress to extend Medicaid pay parity 2Health News:Project launched to study evolutionary history of fungi 2Health News:Project launched to study evolutionary history of fungi 3Health News:Project launched to study evolutionary history of fungi 4Health News:Allred Insurance to Open New Burlington Branch Office 2Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 4
... Patient Satisfaction Scores Through Implementing the RROHC Bundle of ... Feb. 27 -- Hansten Healthcare PLLC , a ... and skill development and improving patient satisfaction scores, today ... company as faculty and RROHC Master Coach. , ...
... LAS VEGAS, Feb. 27 Orthopaedic surgeon David ... Specialty Societies (BOS), of the American Academy of Orthopaedic ... Meeting. Dr. Polly will also sit on the Academy,s ... in the Department of Orthopaedic Surgery at the University ...
... United States have used yeast and mammalian cells to ... Parkinson,s disease. , Yeasts are single cell organisms, ... that of cells found in animals and humans. Yeasts ... and offer the ability to screen or test thousands ...
... Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) ... procedure pursuant to Law 223/1991 concerning its Bresso, Italy, ... total of 62 employees. Within 75 days of ... Trade Unions, will review solutions that may reduce the ...
... shares poetry author,s two-year period of severe depressionBROOKLYN, N.Y., ... Arthur F. Temple kept a journal, in which the ... had become intolerable, and the result is this fascinating ... ).In nearly 100 poems, Temple shares his heartfelt feelings ...
... Driven by Demand for Branded Products- Adjusted Diluted EPS ... 2009 Adjusted EPS Guidance Range of $2.59 - $2.67CHADDS ... ENDP ) today reported double-digit percentage growth in ... the fourth quarter and full year ended December 31, ...
Cached Medicine News:Health News:Relationship and Results Oriented Healthcare Announces New Faculty With Impressive Patient Satisfaction Scores 2Health News:David W. Polly Jr., MD, Elected Secretary of Academy Board of Specialty Societies 2Health News:How yeast is helping us to understand Parkinson's Disease 2Health News:How yeast is helping us to understand Parkinson's Disease 3Health News:CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center 2Health News:CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center 3Health News:CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center 4Health News:CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center 5Health News:Journey into the Dark Recesses of the Subconscious Mind 2Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 2Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 3Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 4Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 5Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 6Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 7Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 8Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 9Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 10Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 11Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 12Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 13Health News:Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results 14
(Date:9/22/2014)... Research and Markets  has announced the addition of ... to their offering. This newly published ... publication available covering the neurotechnology industry. The report takes ... growth rates in four key segments of the neurotechnology ... the number of systems to be sold, worldwide revenue, ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s National ... Monday, Sept. 29 at 5 p.m. EDT for ... competition, in response to continued strong interest from ... each will be awarded to the winning presentations ... Innovation Symposium hosted by Children,s National in October. ...
(Date:9/22/2014)... 2014 Decision Resources Group finds that by the ... be worth $2 billion (U.S. dollars), increasing at a compound ... years (to 2018). This growth comes as Chile ... and 4.9 percent expected over the next three to five ... but highly competitive. The pharmaceutical market is dominated by prescription ...
Breaking Medicine Technology:The Market for Neurotechnology: 2014-2018 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3
The WADiana Compact is a fully automated immuno-haematology analyser, easy to use with maximum security including clot detection and ensuring no contamination....
... on patented microplate agglutination technology. Its is ... donor ABO/Rh testing. PK7200 also handles weak ... antibody detection. The Automated Microplate System delivers ... proven reliability that for the past generation ...
... Tecan Haemotyper is an automated ... The Tecan Haemotyper combines a ... platform with the DiaMed agglutination ... process DiaMed-ID cards and microplates ...
... Since the early 1990s, the "Reversed" ... shoulder surgeons with great success. More recently, ... United States have begun to champion this ... go with it. This reversed technology is ...
Medicine Products: